Merz and Kvvit Partner to Expand INBRIJA Access
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
Alzheimer’s Disease ASCO 2026 Autoimmune Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development EMA FDA fda approval FDA clearance GCP Gene Therapy Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation Phase 1 trial Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
FRANKFURT, Germany and GANZHOU, China, May 26, 2026 Merz Therapeutics GmbH and Jiangxi Kvvit Pharmaceutical Co. Ltd. have announced...
INDIANAPOLIS, United States, May 26, 2026 Eli Lilly and Company has announced three major biotechnology acquisitions aimed at significantly...
